<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33583226</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>14</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1473-2300</ISSN><JournalIssue CitedMedium="Internet"><Volume>49</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Journal of international medical research</Title><ISOAbbreviation>J Int Med Res</ISOAbbreviation></Journal><ArticleTitle>Quantitative susceptibility-weighted imaging in amyotrophic lateral sclerosis with 3.0 T magnetic resonance imaging.</ArticleTitle><Pagination><StartPage>300060521992222</StartPage><MedlinePgn>300060521992222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">0300060521992222</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1177/0300060521992222</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate alterations in phase-shift values in the gray matter of patients with amyotrophic lateral sclerosis (ALS) using susceptibility-weighted imaging (SWI).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twenty patients with definite or probable ALS and 19 age- and sex-matched healthy controls were enrolled. SWI was performed using a 3.0 T magnetic resonance imaging scanner. Phase-shift values were measured in corrected phase images using regions of interest, which were placed on the bilateral precentral gyrus, frontal cortex, caudate nucleus, globus pallidus, and putamen.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Phase-shift values of the precentral gyrus were significantly lower in ALS patients (-0.176&#x2009;&#xb1;&#x2009;0.050) than in the control group (-0.119&#x2009;&#xb1;&#x2009;0.016) on SWI. The average phase-shift values of the frontal cortex, caudate nucleus, globus pallidus, and putamen in ALS patients (-0.089&#x2009;&#xb1;&#x2009;0.023, -0.065&#x2009;&#xb1;&#x2009;0.016, -0.336&#x2009;&#xb1;&#x2009;0.191, and -0.227&#x2009;&#xb1;&#x2009;0.101, respectively) were not significantly different from those in the healthy controls (-0.885&#x2009;&#xb1;&#x2009;0.015, -0.079&#x2009;&#xb1;&#x2009;0.018, -0.329&#x2009;&#xb1;&#x2009;0.136, and -0.229&#x2009;&#xb1;&#x2009;0.083, respectively).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Compared with healthy controls, ALS patients had a lower phase-shift value in the precentral gyrus, which may be related to abnormal iron overload. Thus, SWI is a potential method for identifying ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Meng-Yu</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Department of Radiology, First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhi-Ye</ForeName><Initials>ZY</Initials><Identifier Source="ORCID">0000-0002-5463-8013</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Hainan Hospital of Chinese PLA General Hospital, Sanya, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jin-Feng</ForeName><Initials>JF</Initials><AffiliationInfo><Affiliation>Department of Radiology, First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Hua-Feng</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Department of Radiology, First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Lin</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-3380-3040</Identifier><AffiliationInfo><Affiliation>Department of Radiology, First Medical Center of Chinese PLA General Hospital, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Int Med Res</MedlineTA><NlmUniqueID>0346411</NlmUniqueID><ISSNLinking>0300-0605</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">phase-shift values</Keyword><Keyword MajorTopicYN="N">quantitative susceptibility mapping</Keyword><Keyword MajorTopicYN="N">susceptibility-weighted imaging</Keyword></KeywordList><CoiStatement><b>Declaration of conflicting interest:</b> The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>15</Day><Hour>5</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33583226</ArticleId><ArticleId IdType="pmc">PMC7890729</ArticleId><ArticleId IdType="doi">10.1177/0300060521992222</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Plaitakis A, Constantakakis E. Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis. Brain Res Bull 1993; 30: 381&#x2013;386. DOI: 10.1016/0361-9230(93)90269-h.</Citation><ArticleIdList><ArticleId IdType="pubmed">8457887</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee NY, Kang YS. Taurine protects glutamate neurotoxicity in motor neuron cells. Adv Exp Med Biol 2017; 975: 887&#x2013;895. DOI: 10.1007/978-94-024-1079-2_70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28849508</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenblum LT, Trotti D. EAAT2 and the molecular signature of amyotrophic lateral sclerosis. Adv Neurobiol 2017; 16: 117&#x2013;136. DOI: 10.1007/978-3-319-55769-4_6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6668619</ArticleId><ArticleId IdType="pubmed">28828608</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarchielli P, Pelliccioli GP, Tarducci R, et al. Magnetic resonance imaging and 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. Neuroradiology 2001; 43: 189&#x2013;197. DOI: 10.1007/s002340000472.</Citation><ArticleIdList><ArticleId IdType="pubmed">11305749</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, Xu M, Triantafyllou C, et al. Ultra high-field (7tesla) magnetic resonance spectroscopy in amyotrophic lateral sclerosis. PLoS One 2017; 12: e0177680. DOI: 10.1371/journal.pone.0177680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5428977</ArticleId><ArticleId IdType="pubmed">28498852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan JY, Jeong SY, Van Gelderen P, et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology. PLoS One 2012; 7: e35241. DOI: 10.1371/journal.pone.0035241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328441</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignjatovi&#x107; A, Stevi&#x107; Z, Lavrni&#x107; S, et al. Brain iron MRI: a biomarker for amyotrophic lateral sclerosis. J Magn Reson Imaging 2013; 38: 1472&#x2013;1479. DOI: 10.1002/jmri.24121.</Citation><ArticleIdList><ArticleId IdType="pubmed">23564606</ArticleId></ArticleIdList></Reference><Reference><Citation>Jomova K, Vondrakova D, Lawson M, et al. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 2010; 345: 91&#x2013;104. DOI: 10.1007/s11010-010-0563-x.</Citation><ArticleIdList><ArticleId IdType="pubmed">20730621</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri S, Korner S, Kiaei M. Nrf2/ARE signaling pathway: key mediator in oxidative stress and potential therapeutic target in ALS. Neurol Res Int 2012; 2012: 878030. DOI: 10.1155/2012/878030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3461296</ArticleId><ArticleId IdType="pubmed">23050144</ArticleId></ArticleIdList></Reference><Reference><Citation>Matak P, Matak A, Moustafa S, et al. Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice. Proc Natl Acad Sci U S A 2016; 113: 3428&#x2013;3435. DOI: 10.1073/pnas.1519473113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4822577</ArticleId><ArticleId IdType="pubmed">26929359</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Li C, Zhang T, et al. Deletion of Kir6.2/SUR1 potassium channels rescues diminishing of DA neurons via decreasing iron accumulation in PD. Mol Cell Neurosci 2018; 92: 164&#x2013;176. DOI: 10.1016/j.mcn.2018.08.006.</Citation><ArticleIdList><ArticleId IdType="pubmed">30171894</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba H, Araki T, Ohtomo K, et al. Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology 1993; 189: 843&#x2013;846. DOI: 10.1148/radiology.189.3.8234713.</Citation><ArticleIdList><ArticleId IdType="pubmed">8234713</ArticleId></ArticleIdList></Reference><Reference><Citation>Oba H, Araki T, Monzawa S, et al. . [MR imaging of amyotrophic lateral sclerosis]. Nihon Igaku Hoshasen Gakkai Zasshi 1992; 52: 427&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">1630888</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Ulug AM, Zimmerman RD, et al. The diagnostic utility of FLAIR imaging in clinically verified amyotrophic lateral sclerosis. J Magn Reson Imaging 2003; 17: 521&#x2013;527. DOI: 10.1002/jmri.10293.</Citation><ArticleIdList><ArticleId IdType="pubmed">12720261</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai S, Tang YM, Du L, et al. Hyperintensity of the precentral gyral subcortical white matter and hypointensity of the precentral gyrus on fluid-attenuated inversion recovery: variation with age and implications for the diagnosis of amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 2007; 28: 250&#x2013;254.</Citation><ArticleIdList><ArticleId IdType="pubmed">17296988</ArticleId></ArticleIdList></Reference><Reference><Citation>Halefoglu AM, Yousem DM. Susceptibility weighted imaging: clinical applications and future directions. World J Radiol 2018; 10: 30&#x2013;45. DOI: 10.4329/wjr.v10.i4.30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5971274</ArticleId><ArticleId IdType="pubmed">29849962</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CC, Kwan GNC, Hapugoda S, et al. Susceptibility weighted imaging in acute cerebral ischemia: review of emerging technical concepts and clinical applications. Neuroradiol J 2017; 30: 109&#x2013;119. DOI: 10.1177/1971400917690166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5433592</ArticleId><ArticleId IdType="pubmed">28424015</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehgal V, Delproposto Z, Haacke EM, et al. Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 2005; 22: 439&#x2013;450. DOI: 10.1002/jmri.20404.</Citation><ArticleIdList><ArticleId IdType="pubmed">16163700</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury JJ, Ooi L, Blair IP, et al. The metastability of the proteome of spinal motor neurons underlies their selective vulnerability in ALS. Neurosci Lett 2019; 704: 89&#x2013;94. DOI: 10.1016/j.neulet.2019.04.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">30953736</ArticleId></ArticleIdList></Reference><Reference><Citation>Senda J, Atsuta N, Watanabe H, et al. Structural MRI correlates of amyotrophic lateral sclerosis progression. J Neurol Neurosurg Psychiatry 2017; 88: 901&#x2013;907. DOI: 10.1136/jnnp-2016-314337.</Citation><ArticleIdList><ArticleId IdType="pubmed">28501822</ArticleId></ArticleIdList></Reference><Reference><Citation>Brion S, Plas J. [Lesions of the motor cortex in amyotrophic lateral sclerosis]. Encephale 1986; 12: 81&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">3743521</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwanaga K, Hayashi S, Oyake M, et al. Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci 1997; 146: 139&#x2013;143. DOI: 10.1016/s0022-510x(96)00297-3.</Citation><ArticleIdList><ArticleId IdType="pubmed">9077510</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas M, Jankovic J. Neurodegenerative disease and iron storage in the brain. Curr Opin Neurol 2004; 17: 437&#x2013;442. DOI: 10.1097/01.wco.0000137534.61244.d1.</Citation><ArticleIdList><ArticleId IdType="pubmed">15247539</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams S, Gregory A, Hogarth P, et al. Metabolism and energy requirements in pantothenate kinase-associated neurodegeneration. Mol Genet Metab 2013; 110: 336&#x2013;341. DOI: 10.1016/j.ymgme.2013.06.017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6059611</ArticleId><ArticleId IdType="pubmed">23891537</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostile G, Cicero CE, Giuliano L, et al. Iron and Parkinson's disease: a systematic review and meta-analysis. Mol Med Rep 2017; 15: 3383&#x2013;3389. DOI: 10.3892/mmr.2017.6386.</Citation><ArticleIdList><ArticleId IdType="pubmed">28339068</ArticleId></ArticleIdList></Reference><Reference><Citation>Song N, Wang J, Jiang H, et al. Astroglial and microglial contributions to iron metabolism disturbance in Parkinson's disease. Biochim Biophys Acta Mol Basis Dis 2018; 1864: 967&#x2013;973. DOI: 10.1016/j.bbadis.2018.01.008.</Citation><ArticleIdList><ArticleId IdType="pubmed">29317336</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane DJR, Ayton S, Bush AI. Iron and Alzheimer's disease: an update on emerging mechanisms. J Alzheimers Dis 2018; 64: S379&#x2013;S395. DOI: 10.3233/jad-179944.</Citation><ArticleIdList><ArticleId IdType="pubmed">29865061</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiggermann V, Hametner S, Hern&#xe1;ndez-Torres E, et al. Susceptibility-sensitive MRI of multiple sclerosis lesions and the impact of normal-appearing white matter changes. NMR Biomed 2017; 30: e3727. DOI: 10.1002/nbm.3727.</Citation><ArticleIdList><ArticleId IdType="pubmed">28470768</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JC, Hardy PA, Kucharczyk W, et al. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am J Neuroradiol 1993; 14: 275&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">8456699</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi Y, Sato N, Saito Y, et al. Usefulness of SWI for the detection of iron in the motor cortex in amyotrophic lateral sclerosis. J Neuroimaging 2015; 25: 443&#x2013;451. DOI: 10.1111/jon.12127.</Citation><ArticleIdList><ArticleId IdType="pubmed">24888543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dietrich RB, Bradley WG., Jr. Iron accumulation in the basal ganglia following severe ischemic-anoxic insults in children. Radiology 1988; 168: 203&#x2013;206. DOI: 10.1148/radiology.168.1.3380958.</Citation><ArticleIdList><ArticleId IdType="pubmed">3380958</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, Hartung V, Tietz F, et al. Susceptibility-weighted imaging provides insight into white matter damage in amyotrophic lateral sclerosis. PLoS One 2015; 10: e0131114. DOI: 10.1371/journal.pone.0131114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4481412</ArticleId><ArticleId IdType="pubmed">26110427</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo H, Sekiguchi K, Shimada H, et al. Low signal intensity in motor cortex on susceptibility-weighted MR imaging is correlated with clinical signs of amyotrophic lateral sclerosis: a pilot study. J Neurol 2018; 265: 552&#x2013;561. DOI: 10.1007/s00415-017-8728-0.</Citation><ArticleIdList><ArticleId IdType="pubmed">29356968</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>